Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

NCT: NCT06827262 · RECRUITING

NCT IDNCT06827262
StatusRECRUITING
Start Date2025-03-26
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑